In the present study, mdr1 gene expression was investigated by a sensitive
reverse transcriptase-PCR assay in advanced breast cancer and in correspond
ing adjacent normal tissues obtained before and after treatment with primar
y chemotherapy. Comparatively to normal tissues, a significant induction of
mdr1 expression was observed in untreated tumors (p=0.0222). Similarly, a
significant induction of mdr1 expression was revealed when treated samples
were compared to untreated counterparts (p=0.0222), but no differences were
detected between tumor and normal samples (p=0.3199). Noteworthy, a signif
icant induction of mdr1 gene expression occurred in treated normal samples
comparatively to untreated ones (p=0.0037), and this induction was even mor
e important in normal than in tumoral tissue (p=0.0627). However, neither t
he basal expression nor the induction of mdr1 were correlated with subseque
nt response to chemotherapy or with survival. Thus, in agreement with previ
ous reports, our data show that chemotherapy induce mdr1 gene expression in
breast cancer cells, but they also indicate that a similar phenomenon occu
rs in adjacent normal tissues. Therefore, our results strongly suggest that
mdr1 gene overexpression is not a characteristic of breast malignant cells
, but rather constitutes a general phenomenon occurring both in normal and
tumor cells which could explain at least in part the absence of relationshi
p between mdr1 expression and the clinical outcome of breast cancer patient
s.